Clover Health Investments Corp. Hits New 52-Week High of $5.58

Clover Health Investments Corp. has reached a significant milestone by hitting a new 52-week high of USD 5.58 on June 29, 2026. This achievement marks a notable increase from its 52-week low of USD 1.58, reflecting a substantial upward trend in the stock's performance over the past year. As a small-cap company in the insurance industry, Clover Health has a market capitalization of USD 971 million. Despite facing challenges, the stock has demonstrated resilience, with a one-year performance that outpaces the S&P 500 by 20.53%. However, it is important to note that the company is currently loss-making, as indicated by its negative price-to-earnings ratio and a return on equity of -27.71%. Clover Health's financial metrics also reveal a price-to-book ratio of 3.15, while the company does not offer a dividend yield. The debt-equity ratio remains notably high, indicating a complex financial structure. Overall, the recent price movement highlights Clover Health's evolving position within the insurance sector.